Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?
about
Chondroitin sulfate proteoglycans in the nervous system: inhibitors to repairIn Sickness and in Health: Perineuronal Nets and Synaptic Plasticity in Psychiatric DisordersThe immune response of stem cells in subretinal transplantation6-Sulphated chondroitins have a positive influence on axonal regenerationChondroitin sulfate sulfation motifs as putative biomarkers for isolation of articular cartilage progenitor cellsFibulin-3 is uniquely upregulated in malignant gliomas and promotes tumor cell motility and invasionRoles of the endogenous VEGF receptors flt-1 and flk-1 in astroglial and vascular remodeling after brain injuryComposition of perineuronal net extracellular matrix in rat brain: a different disaccharide composition for the net-associated proteoglycansNgR1 and NgR3 are receptors for chondroitin sulfate proteoglycansChondroitin Sulfate Impairs Neural Stem Cell Migration Through ROCK Activation.A neural extracellular matrix-based method for in vitro hippocampal neuron culture and dopaminergic differentiation of neural stem cells.Perisynaptic aggrecan-based extracellular matrix coats in the human lateral geniculate body devoid of perineuronal nets.PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration.Corticospinal sprouting differs according to spinal injury location and cortical origin in macaque monkeys.The role of the immune system in central nervous system plasticity after acute injury.Proteoglycan abnormalities in olfactory epithelium tissue from subjects diagnosed with schizophreniaToward libraries of biotinylated chondroitin sulfate analogues: from synthesis to in vivo studies.Chondroitin sulfate/dermatan sulfate hybrid chains in the development of cerebellum. Spatiotemporal regulation of the expression of critical disulfated disaccharides by specific sulfotransferases.In vivo imaging of dorsal root regeneration: rapid immobilization and presynaptic differentiation at the CNS/PNS border.N-acetylgalactosamine positive perineuronal nets in the saccade-related-part of the cerebellar fastigial nucleus do not maintain saccade gainChondroitinase ABC I-mediated enhancement of oncolytic virus spread and antitumor efficacy.GlcUAβ1-3Galβ1-3Galβ1-4Xyl(2-O-phosphate) is the preferred substrate for chondroitin N-acetylgalactosaminyltransferase-1.Sprouting, regeneration and circuit formation in the injured spinal cord: factors and activity.Extracellular matrix abnormalities in schizophreniaDecline in arylsulfatase B and Increase in chondroitin 4-sulfotransferase combine to increase chondroitin 4-sulfate in traumatic brain injury.Subpopulations of neurons expressing parvalbumin in the human amygdala.The endogenous proteoglycan-degrading enzyme ADAMTS-4 promotes functional recovery after spinal cord injury.The roles of neuronal and glial precursors in overcoming chondroitin sulfate proteoglycan inhibitionSetting the stage for functional repair of spinal cord injuries: a cast of thousands.Intracerebral chondroitinase ABC and heparan sulfate proteoglycan glypican improve outcome from chronic stroke in ratsSensory Axon Regeneration: A Review from an in vivo Imaging Perspective.Purkinje cell axon collaterals terminate on Cat-301+ neurons in Macaca monkey cerebellum.CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failureIncreased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3.Distribution of N-Acetylgalactosamine-Positive Perineuronal Nets in the Macaque Brain: Anatomy and ImplicationsNeuroprotection against iron-induced cell death by perineuronal nets - an in vivo analysis of oxidative stress.A Neonatal Mouse Spinal Cord Compression Injury ModelActin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth.The injured nervous system: a Darwinian perspective.Total number, distribution, and phenotype of cells expressing chondroitin sulfate proteoglycans in the normal human amygdala.
P2860
Q21284516-D562C435-725D-4723-AD53-BECE3FE88587Q26769948-0411CD5E-2DB6-42F0-9FAA-74282E23AE8CQ26781292-28CFD236-C7D8-4F79-AD57-C1F4042BE25BQ27334388-DE8E71DE-77BD-4FAE-A435-10B155B281D7Q28253390-7E45B08B-7463-47D4-ADCE-D910AF6B61B0Q28263549-FA5DDBD1-0031-42D5-9E68-945AC0A6B093Q28575249-27417615-5FBF-4F8D-A0D7-FBD3205F4F3CQ28576541-8FF651CE-4F2F-48B2-8A09-593E57B79445Q28594524-373F92B2-18BA-4B3C-A103-A9F06F6BFCC2Q30252467-8EEC9000-5777-4DFD-82F9-043134AF6B48Q30539332-4BB68325-2BD8-477E-B1C2-F3E6B89D7D27Q31031622-037F20B5-2E19-4A6E-9915-3788B9B3DEFCQ33610127-0F7646E5-3224-4AF5-9905-DD27E12EAE58Q34162701-C70AE977-0290-4D8D-BBBF-A10262EECF78Q34206790-B975E2F5-E42D-4C9C-B9BB-3B761206CAB8Q34432726-F015EDBF-A869-4FF5-A0FA-641F420032C6Q34478843-F863EADD-06B2-4A66-8EE2-83396B03E26FQ34526441-22A7FF69-4934-4004-BE73-0C632AD31616Q34749899-35C7BF82-AA71-4489-AB95-3D170406A306Q35112697-28349C3E-28D5-40D8-99FA-AC0F4D167161Q35119552-8C0224BA-5A64-44A6-BB4A-C60BD46A04D1Q35126611-21F36B39-B124-482F-BFA5-0C7ECB589B61Q35172135-DEEFC16B-DEA2-49FC-BCEA-7FA14DFC3F8DQ35603175-40AF9C84-3509-4A47-8266-181F47AE2D71Q35893779-131CE531-6575-445B-9B9F-D9F03E125D05Q35904595-D06691B7-17B8-4A7D-99C6-70D7BEB62C11Q35907961-11FBB3B4-A7D8-4D1F-BC92-C653F71E05DCQ35936091-F81B90B7-1492-4AC3-845F-0F6FDC29555DQ36020714-BF5EC7B3-3662-497F-A57F-4B2A65C6A0BDQ36061404-FA72BEF9-AF72-4EA5-8531-78D52D23EE68Q36267846-DDFB4908-75CE-401E-815D-54683B503D44Q36496384-7F06873C-DD28-4F17-9E75-4471E0992CD6Q36499527-E71F6E7B-6C71-4279-A642-9562D2123E87Q36501925-5160F04C-B7F8-47A5-AC5A-543B8D991156Q36528899-370673F9-BAD1-4F22-B5BD-C0AF0AB905E3Q36576454-4D71E6D7-EC3C-46B3-89D9-18024BEE77DBQ36826658-2F534979-51B7-4A7C-80C1-586C402C0EB7Q36951268-04F809C9-C71E-4CD8-A529-0EDC2CE9B67EQ37144604-46F729AF-71B8-4646-8C84-A99C1DDFA6FCQ37228841-48D2CB88-2DB3-4B79-AAA5-86865FB53850
P2860
Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?
@ast
Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?
@en
Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?
@nl
type
label
Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?
@ast
Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?
@en
Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?
@nl
prefLabel
Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?
@ast
Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?
@en
Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?
@nl
P2860
P1433
P1476
Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?
@en
P2093
P2860
P356
10.1111/J.1469-7580.2004.00261.X
P577
2004-01-01T00:00:00Z